FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Florian Deisenhammer

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

Antibody Specificity

Co-author Network

Publications

TOP 3
Viktoria Gredler; Harald Hegen; Bettina Kuenz; Thomas Berger; Florian Deisenhammer; Franziska Di Pauli; Simone Mader; Markus Reindl; Kathrin Schanda; Andreas Lutterotti
Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases.
Harald Hegen; Bettina Kuenz; Andreas Lutterotti; Manuel Schleiser; Thomas Berger; Franziska Di Pauli; Rainer Ehling; Claudia Gneiss; Florian Deisenhammer
Persistency of neutralizing antibodies depends on titer and interferon-beta preparation.
Andreas Lutterotti; Markus Reindl; M Vedovello; Florian Deisenhammer; F DiPauli; Rainer Ehling; Claudia Gneiss; Bettina Kuenz; Thomas Berger
Olfactory threshold is impaired in early, active multiple sclerosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Florian Deisenhammer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Viktoria Gredler; Harald Hegen; Bettina Kuenz; Thomas Berger; Florian Deisenhammer; Franziska Di Pauli; Simone Mader; Markus Reindl; Kathrin Schanda; Andreas Lutterotti
Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases.
Journal of the neurological sciences 2013;328(1-2):77-82.
2012: Harald Hegen; Bettina Kuenz; Andreas Lutterotti; Manuel Schleiser; Thomas Berger; Franziska Di Pauli; Rainer Ehling; Claudia Gneiss; Florian Deisenhammer
Persistency of neutralizing antibodies depends on titer and interferon-beta preparation.
Multiple sclerosis (Houndmills, Basingstoke, England) 2012;18(5):610-5.
2011: Andreas Lutterotti; Markus Reindl; M Vedovello; Florian Deisenhammer; F DiPauli; Rainer Ehling; Claudia Gneiss; Bettina Kuenz; Thomas Berger
Olfactory threshold is impaired in early, active multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2011;17(8):964-9.
2011: Irena Dujmovic; Simone Mader; Kathrin Schanda; Florian Deisenhammer; Nebojsa Stojsavljevic; Jelena Kostic; Thomas Berger; Jelena Drulovic; Markus Reindl
Temporal dynamics of cerebrospinal fluid anti-aquaporin-4 antibodies in patients with neuromyelitis optica spectrum disorders.
Journal of neuroimmunology 2011;234(1-2):124-30.
2011: Franziska Di Pauli; Simone Mader; Kevin Rostasy; Kathrin Schanda; Barbara Bajer-Kornek; Rainer Ehling; Florian Deisenhammer; Markus Reindl; Thomas Berger
Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases.
Clinical immunology (Orlando, Fla.) 2011;138(3):247-54.
2011: Simone Mader; Kristian Pfaller; Kevin Rostasy; Kathrin Schanda; Maria K Storch; Fahmy Aboul-Enein; Thomas Berger; Florian Deisenhammer; Franziska Di Pauli; Jelena Drulovic; Irena Dujmovic; Rainer Ehling; Viktoria Gredler; Harald Hegen; Sven Jarius; Peter Koson; W Kristoferitsch; Bettina Kuenz; Andreas Lutterotti; Markus Reindl
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.
Journal of neuroinflammation 2011;8():184.
2011: Rainer Ehling; Claudia Gneiss; Harald Hegen; Bettina Kuenz; Peter Lackner; Andreas Lutterotti; Franziska Di Pauli; Thomas Berger; Florian Deisenhammer; Wolfram Santner; Michael Schocke; Markus Reindl
Fibrinogen is not elevated in the cerebrospinal fluid of patients with multiple sclerosis.
Fluids and barriers of the CNS 2011;8(1):25.
2010: alban millonig; Harald Hegen; Franziska Di Pauli; Rainer Ehling; Claudia Gneiss; Martina Hoelzl; Bettina Künz; Andreas Lutterotti; Dagmar Rudzki; Thomas Berger; Markus Reindl; Florian Deisenhammer
Natalizumab treatment reduces endothelial activity in MS patients.
Journal of neuroimmunology 2010;227(1-2):190-4.
2010: Harald Hegen; Julia Wanschitz; Rainer Ehling; Florian Deisenhammer; Wolfgang N Löscher; Markus Reindl; Thomas Berger
Anti-alpha B-crystallin immunoreactivity in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Journal of the peripheral nervous system : JPNS 2010;15(2):150-2.
2010: Irena Dujmovic; Florian Deisenhammer
Stability of cerebrospinal fluid/serum glucose ratio and cerebrospinal fluid lactate concentrations over 24 h: analysis of repeated measurements.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2010;48(2):209-12.
2010: Franziska Di Pauli; Viktoria Gredler; Bettina Kuenz; Andreas Lutterotti; Rainer Ehling; Claudia Gneiss; Michael Schocke; Florian Deisenhammer; Markus Reindl; Thomas Berger
Features of intrathecal immunoglobulins in patients with multiple sclerosis.
Journal of the neurological sciences 2010;288(1-2):147-50.
2010: Peter Lackner; Elif Guengoer; Ronny Beer; Gregor Broessner; Raimund Helbok; Florian Deisenhammer; Erich Schmutzhard; Bettina Pfausler
IgG-index predicts neurological morbidity in patients with infectious central nervous system diseases.
BMC infectious diseases 2010;10():202.
2009: Claudia Gneiss; Pia-Maria Koudouovoh-Tripp; Stefan Ropele; Thaddäus Gotwald; Rainer Ehling; Andreas Lutterotti; Franz Aichner; Gunther Ladurner; Christian Eggers; Franz Schautzer; Bettina Künz; alban millonig; Engelbert Aspeck; Markus Reindl; Thomas Berger; Franz Fazekas; Florian Deisenhammer
Influence of interferon-beta therapy switching on neutralizing antibody titres: results from the Austrian Switch Study.
Multiple sclerosis (Houndmills, Basingstoke, England) 2009;15(12):1481-8.
2009: alban millonig; D Rudzki; M Hölzl; Rainer Ehling; Claudia Gneiss; B Künz; Thomas Berger; Markus Reindl; Florian Deisenhammer
High-dose intravenous interferon beta in patients with neutralizing antibodies (HINABS): a pilot study.
Multiple sclerosis (Houndmills, Basingstoke, England) 2009;15(8):977-83.
2009: Florian Deisenhammer; Robert Egg; G Giovannoni; B Hemmer; Axel Petzold; Finn Sellebjerg; C Teunissen; H Tumani
EFNS guidelines on disease-specific CSF investigations.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2009;16(6):760-70.
2009: Florian Deisenhammer
Neutralizing antibodies to interferon-beta and other immunological treatments for multiple sclerosis: prevalence and impact on outcomes.
CNS drugs 2009;23(5):379-96.
2008: F Di Pauli; Markus Reindl; Rainer Ehling; F Schautzer; Claudia Gneiss; Andreas Lutterotti; Ej O'Reilly; Kl Munger; Florian Deisenhammer; A Ascherio; Thomas Berger
Smoking is a risk factor for early conversion to clinically definite multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(8):1026-30.
2008: Steve Hoffmann; Sabine Cepok; Verena Grummel; Klaus Lehmann-Horn; Jorg Hackermuller; Jörg Hackermueller; Peter F Stadler; Hans-Peter Hartung; Achim Berthele; Florian Deisenhammer; Ralf Wassmuth; Ralf Wasmuth; Bernhard Hemmer
HLA-DRB1*0401 and HLA-DRB1*0408 are strongly associated with the development of antibodies against interferon-beta therapy in multiple sclerosis.
American journal of human genetics 2008;83(2):219-27.
2008: alban millonig; A Dressel; D Bahner; A Bitsch; T Bogumil; E Elitok; B Kitze; H Tumani; F Weber; Claudia Gneiss; Florian Deisenhammer
MxA protein--an interferon beta biomarker in primary progressive multiple sclerosis patients.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2008;15(8):822-6.
2008: Claudia Gneiss; M Brugger; alban millonig; A Fogdell-Hahn; D Rudzki; J Hillert; Thomas Berger; Markus Reindl; Florian Deisenhammer
Comparative study of four different assays for the detection of binding antibodies against interferon-beta.
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(6):830-6.
2008: Julia Wanschitz; Rainer Ehling; Wolfgang N Löscher; Betinna Künz; Florian Deisenhammer; Jens Kuhle; Herbert Budka; Markus Reindl; Thomas Berger
Intrathecal anti-alphaB-crystallin IgG antibody responses: potential inflammatory markers in Guillain-Barré syndrome.
Journal of neurology 2008;255(6):917-24.
2008: Sabine Scholl-Bürgi; Edda Haberlandt; Peter Heinz-Erian; Florian Deisenhammer; Ursula Albrecht; Sara Baumgartner Sigl; Markus Rauchenzauner; Hanno Ulmer; Daniela Karall
Amino acid cerebrospinal fluid/plasma ratios in children: influence of age, gender, and antiepileptic medication.
Pediatrics 2008;121(4):e920-6.
2008: Bettina Kuenz; Andreas Lutterotti; Rainer Ehling; Claudia Gneiss; Monika Haemmerle; Carolyn Rainer; Florian Deisenhammer; Michael Schocke; Thomas Berger; Markus Reindl
Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis.
PloS one 2008;3(7):e2559.
2008: Rachel Farrell; Klaus Bendtzen; Antonio Bertolotto; Berwyn Clark; Manuel Comabella; Florian Deisenhammer; Anna Fogdell-Hahn; Gavin Giovannoni; Hans Peter Hartung; Bernard Hemmer; Jan Hillert; Ludwig Kappos; Joep Killestein; Raija Lindberg; Xavier Montalban; Chris Polman; Per Soelberg Sorensen
Re: Neutralizing antibodies to interferon beta-1b are not associated with disease worsening in multiple sclerosis.
The Journal of international medical research 2008;36(1):204-8; author reply 208-10.
2007: Chris H Polman; Florian Deisenhammer; Gavin Giovannoni; Joep Killestein; Huub Schellekens
Re: Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Neurology 2007;69(15):1553-4; author reply 1555.
2007: Bettina Kuenz; Thomas Berger; Florian Deisenhammer; Markus Reindl
Diagnostic biomarkers in multiple sclerosis.
Expert opinion on medical diagnostics 2007;1(2):225-33.
2007: Hans-P Hartung; Chris H Polman; Antonio Bertolotto; Florian Deisenhammer; Gavin Giovannoni; Eva Havrdova; Bernhard Hemmer; Jan Hillert; Ludwig Kappos; Bernd C Kieseier; Joep Killestein; Christophe Malcus; Manuel Comabella; Andrew R Pachner; Huub Schellekens; Finn Sellebjerg; Krzysztof Selmaj; Per Soelberg Sorensen
Neutralising antibodies to interferon beta in multiple sclerosis : expert panel report.
Journal of neurology 2007;254(7):827-37.
2006: Claudia Gneiss; P Tripp; F Reichartseder; Robert Egg; Rainer Ehling; Andreas Lutterotti; Michael Khalil; Bettina Kuenz; Irmgard Mayringer; Markus Reindl; Thomas Berger; Florian Deisenhammer
Differing immunogenic potentials of interferon beta preparations in multiple sclerosis patients.
Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12(6):731-7.
2006: Andreas Lutterotti; Bettina Kuenz; Viktoria Gredler; Michael Khalil; Rainer Ehling; Claudia Gneiss; Robert Egg; Florian Deisenhammer; Thomas Berger; Markus Reindl
Increased serum levels of soluble CD14 indicate stable multiple sclerosis.
Journal of neuroimmunology 2006;181(1-2):145-9.
2006: Piotr Lewczuk; Georg Beck; Oliver Ganslandt; Hermann Esselmann; Florian Deisenhammer; Axel Regeniter; Hela-Felicitas Petereit; Hayrettin Tumani; Andreas Gerritzen; Patrick Oschmann; Johannes Schröder; Peter Schönknecht; Klaus Zimmermann; Harald Hampel; Katharina Bürger; Markus Otto; Sabine Haustein; Karin Herzog; Rainer Dannenberg; Ulrich Wurster; Mirko Bibl; Juan Manuel Maler; Udo Reubach; Johannes Kornhuber; Jens Wiltfang
International quality control survey of neurochemical dementia diagnostics.
Neuroscience letters 2006;409(1):1-4.
2006: Florian Deisenhammer; A Bartos; Robert Egg; N E Gilhus; G Giovannoni; S Rauer; Finn Sellebjerg
Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2006;13(9):913-22.
2006: Claudia Gneiss; P Tripp; Rainer Ehling; Michael Khalil; Andreas Lutterotti; Robert Egg; Irmgard Mayringer; B Künz; Thomas Berger; Markus Reindl; Florian Deisenhammer
Interferon-beta antibodies have a higher affinity in patients with neutralizing antibodies compared to patients with non-neutralizing antibodies.
Journal of neuroimmunology 2006;174(1-2):174-9.
2006: Michael Khalil; Markus Reindl; Andreas Lutterotti; Bettina Kuenz; Rainer Ehling; Claudia Gneiss; Peter Lackner; Florian Deisenhammer; Thomas Berger
Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments.
Journal of neuroimmunology 2006;174(1-2):147-56.
2005: P S Sørensen; Florian Deisenhammer; P Duda; R Hohlfeld; K-M Myhr; J Palace; C Polman; C Pozzilli; C Ross
Guidelines on use of anti-IFN-beta antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-beta antibodies in multiple sclerosis.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2005;12(11):817-27.
2005: Thomas Berger; Florian Deisenhammer
Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis.
The New England journal of medicine 2005;353(16):1744-6; author reply 1744-6.
2005: Bettina Kuenz; Andreas Lutterotti; Michael Khalil; Rainer Ehling; Claudia Gneiss; Florian Deisenhammer; Markus Reindl; Thomas Berger
Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis.
Journal of neuroimmunology 2005;167(1-2):143-9.
2005: Irmgard Mayringer; B Timeltaler; Florian Deisenhammer
Correlation between the IgG index, oligoclonal bands in CSF, and the diagnosis of demyelinating diseases.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2005;12(7):527-30.
2005: Mark S Freedman; Edward J Thompson; Florian Deisenhammer; Gavin Giovannoni; Guy Grimsley; Geoff Keir; Sten Ohman; Michael K Racke; Mohammad Sharief; C J M Sindic; Finn Sellebjerg; Wallace W Tourtellotte
Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement.
Archives of neurology 2005;62(6):865-70.
2004: Andreas Bitsch; Alexander Dressel; Kathrin Meier; Timon Bogumil; Florian Deisenhammer; Hayrettin Tumani; Bernd Kitze; Sigrid Poser; Frank Weber
Autoantibody synthesis in primary progressive multiple sclerosis patients treated with interferon beta-1b.
Journal of neurology 2004;251(12):1498-501.
2004: Rainer Ehling; Andreas Lutterotti; Julia Wanschitz; Michael Khalil; Claudia Gneiss; Florian Deisenhammer; Markus Reindl; Thomas Berger
Increased frequencies of serum antibodies to neurofilament light in patients with primary chronic progressive multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(6):601-6.
2004: Claudia Gneiss; Markus Reindl; Andreas Lutterotti; Rainer Ehling; Robert Egg; Michael Khalil; Thomas Berger; Florian Deisenhammer
Interferon-beta: the neutralizing antibody (NAb) titre predicts reversion to NAb negativity.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(5):507-10.
2004: Florian Deisenhammer; Huub Schellekens; Antonio Bertolotto
Measurement of neutralizing antibodies to interferon beta in patients with multiple sclerosis.
Journal of neurology 2004;251 Suppl 2():II31-9.
2004: Antonio Bertolotto; Florian Deisenhammer; Paolo Gallo; Per Sölberg Sørensen
Immunogenicity of interferon beta: differences among products.
Journal of neurology 2004;251 Suppl 2():II15-II24.
2004: Claudia Gneiss; Markus Reindl; Thomas Berger; Andreas Lutterotti; Rainer Ehling; Robert Egg; Florian Deisenhammer
Epitope specificity of neutralizing antibodies against IFN-beta.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2004;24(5):283-90.
2004: Gavin Giovannoni; Florian Deisenhammer
Neutralising antibodies against interferon beta in multiple sclerosis.
Lancet 2004;363(9403):166-7; author reply 168-9.
2003: Markus Reindl; Sabrina Khantane; Rainer Ehling; Kathrin Schanda; Andreas Lutterotti; Claudia Brinkhoff; Thomas Oertle; Martin E Schwab; Florian Deisenhammer; Thomas Berger; Christine E Bandtlow
Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders.
Journal of neuroimmunology 2003;145(1-2):139-47.
2003: Andrew R Pachner; Antonio Bertolotto; Florian Deisenhammer
Measurement of MxA mRNA or protein as a biomarker of IFNbeta bioactivity: detection of antibody-mediated decreased bioactivity (ADB).
Neurology 2003;61(9 Suppl 5):S24-6.
2003: Michael Schocke; Thomas Berger; Stephan Felber; Christian Wolf; Florian Deisenhammer; Christian Kremser; Klaus Seppi; Franz T Aichner
Serial contrast-enhanced magnetic resonance imaging and spectroscopic imaging of acute multiple sclerosis lesions under high-dose methylprednisolone therapy.
NeuroImage 2003;20(2):1253-63.
2003: Thomas Berger; Paul Rubner; Franz Schautzer; Robert Egg; Hanno Ulmer; Irmgard Mayringer; Erika Dilitz; Florian Deisenhammer; Markus Reindl
Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event.
The New England journal of medicine 2003;349(2):139-45.
2003: Gerhard Franz; Ronny Beer; Andreas Kampfl; Klaus Engelhardt; Erich Schmutzhard; Hanno Ulmer; Florian Deisenhammer
Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury.
Neurology 2003;60(9):1457-61.
2003: M Kob; J Harvey; Franz Schautzer; S Kascha; D Bibl; Robert Egg; Markus Reindl; Thomas Berger; Florian Deisenhammer
A novel and rapid assay for the detection of neutralizing antibodies against interferon-beta.
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(1):32-5.
2003: Markus Reindl; Andreas Lutterotti; J Ingram; Kathrin Schanda; Christoph Gassner; Florian Deisenhammer; Thomas Berger; E Lorenz
Mutations in the gene for toll-like receptor 4 and multiple sclerosis.
Tissue antigens 2003;61(1):85-8.
2002: Andreas Lutterotti; Markus Reindl; Christoph Gassner; Katharina Poustka; Kathrin Schanda; Florian Deisenhammer; Thomas Berger
Antibody response to myelin oligodendrocyte glycoprotein and myelin basic protein depend on familial background and are partially associated with human leukocyte antigen alleles in multiplex families and sporadic multiple sclerosis.
Journal of neuroimmunology 2002;131(1-2):201-7.
2002: Eugen Trinka; Erika Dilitz; Iris Unterberger; Gerhard Luef; Florian Deisenhammer; Ulrike Niedermüller; Claudia Thaler; Gerhard Bauer
Non convulsive status epilepticus after replacement of valproate with lamotrigine.
Journal of neurology 2002;249(10):1417-22.
2001: Robert Egg; Markus Reindl; Florian Deisenhammer; Christopher Linington; Thomas Berger
Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2001;7(5):285-9.
2001: Markus Reindl; G Knipping; I Wicher; Erika Dilitz; Robert Egg; Florian Deisenhammer; Thomas Berger
Increased intrathecal production of apolipoprotein D in multiple sclerosis.
Journal of neuroimmunology 2001;119(2):327-32.
2001: Florian Deisenhammer; Markus Reindl; Thomas Berger
Immunoglobulin subclasses in patients with neutralizing and nonneutralizing antibodies against IFN-beta1b.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2001;21(3):167-71.
2000: Florian Deisenhammer; Irmgard Mayringer; J Harvey; Erika Dilitz; T Gasse; D Stadlbauer; Markus Reindl; Thomas Berger
A comparative study of the relative bioavailability of different interferon beta preparations.
Neurology 2000;54(11):2055-60.
2000: Günther Stockhammer; Werner Poewe; Sonja Burgstaller; Florian Deisenhammer; Armin Muigg; Stefan Kiechl; Erich Schmutzhard; Hans Maier; Stephan Felber; Petra Schumacher; Eberhard Gunsilius; Guenther Gastl
Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis.
Neurology 2000;54(8):1670-6.
1999: Markus Reindl; Christopher Linington; U Brehm; Robert Egg; Erika Dilitz; Florian Deisenhammer; Werner Poewe; Thomas Berger
Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
Brain : a journal of neurology 1999;122 ( Pt 11)():2047-56.
1999: Arthur Kaser; Florian Deisenhammer; T Berger; Herbert Tilg
Interferon-beta 1b augments activation-induced T-cell death in multiple sclerosis patients.
Lancet 1999;353(9162):1413-4.
1999: Florian Deisenhammer; Markus Reindl; J Harvey; T Gasse; Erika Dilitz; Thomas Berger
Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies.
Neurology 1999;52(6):1239-43.
1996: Thomas Berger; Florian Deisenhammer
[Clinical aspects and diagnosis of multiple sclerosis].
Wiener medizinische Wochenschrift (1946) 1996;146(19-20):504-13.
1994: Florian Deisenhammer; P Pohl; S Bösch; Christoph Schmidauer
Acute cerebellar ataxia after immunisation with recombinant hepatitis B vaccine.
Acta neurologica Scandinavica 1994;89(6):462-3.
1993: H Rössler; H J Battista; Florian Deisenhammer; Verena Günther; P Pohl; L Prokop; Y Riemer
Methadone-substitution and driving ability.
Forensic science international 1993;62(1-2):63-6.
1993: Florian Deisenhammer; Johann Willeit; Christoph Schmidauer; Stefan Kiechl; P Pohl
[Membranous lipodystrophy (Nasu-Hakola disease)].
Der Nervenarzt 1993;64(4):263-5.
1992: P Pohl; Georg Riccabona; E Hilty; Florian Deisenhammer; H Rösslér; Robert Zangerle; F Gerstenbrand
Double-tracer SPECT in patients with AIDS encephalopathy: a comparison of 123I-IMP with 99Tcm-HMPAO.
Nuclear medicine communications 1992;13(8):586-92.
1992: J Willeit; F Aichner; Stephan Felber; K Berek; Florian Deisenhammer; Stefan Kiechl; F Gerstenbrand
Superficial siderosis of the central nervous system: report of three cases and review of the literature.
Journal of the neurological sciences 1992;111(1):20-5.
1991: Johann Willeit; Florian Deisenhammer; G Ransmayr; F Gerstenbrand
[Orthostatic tremor].
Deutsche medizinische Wochenschrift (1946) 1991;116(40):1509-12.